MCM
ICCC icon

Militia Capital Management’s ImmuCell ICCC Stock Holding History

Militia Capital Management’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$101K Sell
10,000
-8,000
-44% -$70.7K ﹤0.01% 277
2026
Q1 		$114K Buy
+18,000
New +$115K 0.01% 266

Other funds holding ICCC

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
S
Steadtrust Allen, Texas $198M AUM 99.37% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Militia Capital Management's ICCC Position: Q2 2026 in Review

Militia Capital Management reduced its ImmuCell (ICCC) stake by 44% in Q2 2026, selling an estimated $70.7K and leaving 10,000 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #277.

Militia Capital Management first reported a position in ICCC in Q1 2026 and has held it in 2 quarters since. The position peaked at $114K in Q1 2026. 30 funds tracked by Wall St. Rank hold ICCC as of Q2 2026.

  • Militia Capital Management held 10,000 shares of ImmuCell worth $101K as of Q2 2026.
  • Militia Capital Management sold 8,000 ImmuCell shares in Q2 2026, an estimated $70.7K.
  • ImmuCell made up ﹤0.01% of Militia Capital Management's portfolio in Q2 2026, its #277 holding.
  • Militia Capital Management first reported a position in ImmuCell in Q1 2026 and has held it in 2 quarters since.
  • Militia Capital Management's ImmuCell position peaked at $114K in Q1 2026.
  • 30 funds tracked by Wall St. Rank held ImmuCell as of Q2 2026.

Based on Militia Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.